PIN23 COST-EFFECTIVENESS ANALYSIS OF THE IMPLEMENTATION OF A QUADRIVALENT (6,1 1, 16,18 TYPES) HUMAN PAPILLOMAVIRUS VACCINE TO THE EXISTING BELGIAN CERVICAL CANCER SCREENING PROGRAMME
L Annemans, V Remy, N LargeronVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65530-1
File:
PDF, 86 KB
english, 2007